Skip to main content

Journal of Cancer Education

Ausgabe 6/2023

Inhalt (25 Artikel)

Editorial

The Value of Networking in Cancer Education and Capacity Building

Emad Shash, Ghada A. Soliman, Wahid Al-kharusi, Maha Yahia, Julius Mwaiselage, Dewani Mesemo, Chacha Mwita, Samuel Gathere, Leo Masamba, Henda Rais, Mustafa Hussein, Victoria Ngo, Pedro Mateu Gelabert, Hany Hussein, Robert M. Chamberlain, Amr S. Soliman

Open Access

Attitudes and Perception of the REFLECT Communication Curriculum for Clinical Oncology Graduate Medical Education

Brady S. Laughlin, Natalie Langley, Samir H. Patel, Katherine Kough, Brenda Ernst, Jonathan B. Ashman, William G. Rule, Tamara Z. Vern-Gross

“Cancer Education on Wheels,” a Novel Cost-Effective Method in Creating Awareness in the Community: a Pilot Study

Suresh Rao, Pratima Rao, Rajesh Shetty, Nithesh Chandra Gatty, Durgadas Adappa, Sucharitha Suresh, Manjeshwar Shrinath Baliga

How Good Is Online Information for Patients on the Treatment for Luminal Gastrointestinal Cancers? A Comprehensive Evaluation in English and Spanish

Renato Beas, Cielo Cabanillas-Ramirez, Diego Izquierdo-Veraza, Andres Chapoñan-Lavalle, Dalton Norwood, Karina Sato-Espinoza, Adrian Riva-Moscoso, Isabella Ribaudo, Mirian Ramirez-Rojas, Azizullah Beran, Eleazar E. Montalvan-Sanchez

Concept Mapping with Black Men: Barriers to Prostate Cancer Screening and Solutions

Meghan Tipre, Claudia Hardy, Tara Bowman, Marcus Glover, Patricia Gullet, Denise Baity, Kathy Levy, Monica L Baskin

Association of Preventive Care Attitudes and Beliefs with Colorectal Cancer Screening History among African American Patients of Community Health Centers

John S. Luque, Gebre-Egziabher Kiros, Matthew Vargas, Deloria R. Jackson, Olayemi O. Matthew, Tifini D. Austin, Rima Tawk, Askal A. Ali, Cynthia M. Harris, Kristin Wallace, Clement K. Gwede

Digital Storytelling as a Tool to Increase Colorectal Cancer Screening Intention in a Latinx Church Community

Vicky Gomez, Nazineen Kandahari, Daniela Curiel, Andrew Carter, Carol P. Somkin, Amani M. Allen

Exploring Family Physician Training Needs to Improve Cancer Patient Care

Marissa Sherwood, Janet Papadakos, Kulamahan Kulasegaram, Maria A. Martimianakis, Edward Kucharski, Meredith Giuliani

Evaluation of a Radiation Oncology Microclerkship as a Component of Medical Student Education

Shyamala Subramanian, Pranav Parikh, Joshua A. Kra, Pierre D. Maldjian, Susanne Walther, Sung Kim, Nicholas J. DeNunzio, Matthew J. Abrams, Steve E. Braunstein, Jillian R. Gunther, Malcolm D. Mattes

Impact of the Integrative Oncology Scholars Program on Oncology Providers’ Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care

Zachary O. Kadro, Sara Snyder, Rita Benn, Judith M. Fouladbakhsh, Heather Greenlee, Richard E. Harris, N. Lynn Henry, Kristin C. Klein, Sabrina Mayhew, Lisa Spratke, Eleanor M. Walker, Bradley Zebrack, Suzanna M. Zick

Correction

Correction to: Impact of the Integrative Oncology Scholars Program on Oncology Providers’ Key Knowledge of Dietary Supplements and Antioxidants for Providing Evidence-based Oncology Care

Zachary O. Kadro, Sara Snyder, Rita Benn, Judith M. Fouladbakhsh, Heather Greenlee, Richard E. Harris, N. Lynn Henry, Kristin C. Klein, Sabrina Mayhew, Lisa Spratke, Eleanor M. Walker, Bradley Zebrack, Suzanna M. Zick

An Interactive Educational Tool to Improve Human Papillomavirus Vaccine Knowledge and Recommendation Among Nurses

Shuk On Annie Leung, Alessandro Villa, Eileen Duffey-Lind, Kelly Welch, Theresa Jabaley, Marilyn Hammer, Sarah Feldman

Evaluation of the Quality and Comprehensiveness of YouTube Videos Discussing Pancreatic Cancer

Alexander J. Didier, Lauren Fang, Jennifer Stiene, Caleb T. Spencer, Danae M. Hamouda

Open Access

The ISAC Paradigm to Tame Oral Cancer in Saudi Arabia: A Quasi-experimental Study

Mohammed Jafer, Ibtisam Moafa, Ciska Hoving, Math Candel, Abdulrahman A. Kaabi, Bart Van Den Borne

Knowledge, Attitude, and Practice of Breast Cancer Patients Toward Lymphedema Complications: Cross-Sectional Study

Yan Qin, Junjun Lu, Shanze Li, Jie Huang, Wenjing Teng, Yue Wu, Wanqing Chen, Lizhen Wang, Weikang Zhu

Open Access

Impact of Practical Online Lessons on Chinese Medical Students’ Perception of Radiation Oncology

Ziye Zheng, Yuxuan Wang, Fuquan Zhang, Jiawei Zhu, Jing Shen, Qingyu Meng, Bei Wang, Bing Zhou, Wei Tian, Lihua Yu, Junfang Yan

Original Research Paper

Pre-diagnosis Symptoms, Attributed Causes, and Healthcare Seeking Assets of Younger Colorectal Cancer Survivors

Jackie Knight Wilt, Laura A Siminoff, Maria D. Thomson

Design and Implementation of a Multidisciplinary High-Fidelity Simulation Course for the Management of Malignant Spinal Cord Compression

Yiming Michael Zhu, Brian Chwyl, Susan Fawcett, Fan Yang, Heather Warkentin, Sunita Ghosh, Brock Debenham, Adele Duimering, Mustafa Al Balushi

Genomic Literacy among Nurses in Jordan: A Population-based Study

Aladeen Alloubani, Majeda AL-Ruzzieh, Nour Khawaja, Laila Akhu-Zaheya

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.